ArticleCurrent issues in molecular biology2025

In Silico Multitarget Profiling of Non-Selective Beta-Blockers Highlights Their Potential as Key Agents in Breast Cancer Adjuvant Therapy via ADRB2, ERBB2, and NPYR Receptors.

Felipe Muñoz-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.